NCT04102917View on ClinicalTrials.gov

Diagnostic Performance and Prognostic Ability of the QFR

CompletedOBSERVATIONAL
Enrollment

915

Participants

Timeline

Start Date

January 1, 2012

Primary Completion Date

May 31, 2018

Study Completion Date

June 14, 2019

Conditions
Ischemic Heart Disease
Interventions
DIAGNOSTIC_TEST

QFR assessment

The quantitative flow ratio (QFR) is a novel angiography-based method for noninvasive functional assessment of intermediate coronary lesions.

Trial Locations (1)

06591

Seoul Saint Mary's Hospital, Seoul

All Listed Sponsors
collaborator

National Research Foundation of Korea

OTHER

collaborator

Seoul Saint Mary's Hospital

UNKNOWN

collaborator

Incheon Saint Mary's Hospital

UNKNOWN

collaborator

Seoul Saint Paul's Hospital

UNKNOWN

collaborator

Uijeongbu Saint Mary's Hospital

UNKNOWN

lead

Seoul St. Mary's Hospital

OTHER

NCT04102917 - Diagnostic Performance and Prognostic Ability of the QFR | Biotech Hunter | Biotech Hunter